Cystic fibrosis‐related diabetes

Diabetic Medicine - Tập 20 Số 6 - Trang 425-436 - 2003
Alasdair Mackie1, S. J. Thornton2,1, F. Edenborough2,1
1Diabetes and Endocrine Centre and
2Adult Cystic Fibrosis Unit, Northern General Hospital, Sheffield, UK

Tóm tắt

AbstractDiabetes mellitus (DM) has been recognized as a complication of cystic fibrosis (CF) for almost 50 years and commonly develops around 20 years of age. The prevalence increases with age and, with improved survival of those with CF, approaches 30% in certain centres. Its development appears to have a significant impact on pulmonary function and may increase mortality by up to six‐fold. Subjects with CF are rarely ketosis‐prone and phenotypically lie between Type 1 and Type 2 DM. Microvascular complications are recognized, although paucity of data does not permit a clear description of their natural history. An annual oral glucose tolerance test from the age of 10 years is recommended for screening, but logistical difficulties have led some groups to develop specific algorithms to aid diagnosis. Insulin sensitivity in CF is much debated and may depend upon the degree of glucose intolerance. Insulin resistance occurs in the presence of infection, corticosteroid usage and hyperglycaemia, whilst hepatic insulin resistance is considered an adaptation to CF. There is no universal consensus on the treatment of hyperglycaemia. With increased longevity of individuals with CF, greater numbers will develop diabetes and the diabetes physician is destined to play a greater role in the multidisciplinary CF team.Diabet. Med. 20, 425–436 (2003)

Từ khóa


Tài liệu tham khảo

10.1111/j.1365-3016.1993.tb00390.x

Lewis PA., 1995, Cystic Fibrosis, 1

Fanconi G, 1936, Das coeliakiesyndrom bei angeborener zysticher Pankreasfibromatose und Bronkiektasen, Wien Med Wochenschr, 86, 753

Landsteiner K., 1905, Darmverschluss durch eingedicktes Meconium. Pankreatitis, Zentrabl Allg Pathol, 16, 903

Garrod AE, 1912, Congenital familial steatorrhoea, Q J Med, 6, 242

Super M., 1992, Milestones in cystic fibrosis, Br Med Bull, 48, 717, 10.1093/oxfordjournals.bmb.a072574

10.1126/science.2570460

10.1126/science.2772657

10.1126/science.2475911

10.1056/NEJM199011293232203

Kristidis P, 1992, Genetic determinants of exocrine pancreas function in cystic fibrosis, Am J Hum Genet, 50, 1178

10.1002/1099-0496(200101)31:1<1::AID-PPUL1000>3.0.CO;2-T

10.1016/0011-5029(93)90028-2

Hodson ME, 1995, Cystic Fibrosis

Yankaskas JR, 1999, Cystic Fibrosis in Adults.

Anderson CM., 1967, Long‐term study of patients with cystic fibrosis, Mod Probl Pediatr, 10, 344

10.1136/thx.46.12.881

10.1136/thx.51.10.1023

10.1136/thorax.56.10.743

10.1111/j.1651-2227.1982.tb09645.x

10.1016/0895-4356(88)90063-7

10.1016/0140-6736(91)91446-2

Fredericksen B, 1996, Improved survival in the Danish center‐treated cystic fibrosis patients: results of aggressive treatment, Pediatr Pulmonol, 21, 153, 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO;2-R

10.1001/archpedi.1938.01980140114013

Shwachman H, 1955, Mucoviscidosis, Adv Paediatr, 7, 249, 10.1016/S0065-3101(22)00441-8

10.1001/archpedi.1962.02080030625007

10.1136/adc.44.235.351

10.1056/NEJM196908282810901

10.1016/0002-9343(79)90491-1

Robert JJ, 1992, Reserche de facteurs d’intolerance au glucose dans la muscoviscidose, Arch Fr Pediatr, 49, 17

10.1136/bmj.311.7006.655

10.1055/s-2007-1003737

10.1177/014107689909237S07

Charlton J, 2001, Setting up a diabetes/cystic fibrosis service, Diabet Med, 18, 100A

Lanng S, 2000, Diabetes mellitus in cystic fibrosis: a ten‐year prospective study, Diabetologia, 43, 107A

10.1007/BF00201659

10.1016/S0022-3476(88)80315-9

10.1016/S0022-3476(95)70080-3

10.1111/j.1651-2227.1999.tb01127.x

10.1016/S0022-3476(98)70171-4

10.1056/NEJM199310283291804

10.1111/j.1399-0004.1993.tb04445.x

10.1136/adc.66.5.612

10.1136/adc.75.6.546

10.1056/NEJM199507133330204

10.1136/adc.63.10.1234

ZanelliP NeriTM De FantiA BoselliE GrzincichGL BetterleCet al.Genetic and immunological markers of preclinic insulin dependent diabetes mellitus (IDDM) in cystic fibrosis (CF). Workshop of Cystic Fibrosis Sestri Levante Italy1990.

10.1111/j.1651-2227.1993.tb12628.x

Cystic Fibrosis Foundation Patient Registry., 1998, Annual Data Report.

10.1097/00005792-198611000-00004

Reisman J, 1990, Diabetes mellitus in patients with cystic fibrosis: effect on survival, Pediatrics, 86, 374, 10.1542/peds.86.3.374

Thornsteinsson B, 1991, Epidemiology of glucose intolerance in cystic fibrosis, Diabetes, 40, 320A

10.1007/BF01957574

10.1530/eje.0.1340731

10.1164/ajrccm.162.3.9904075

10.1002/ppul.1142

10.1203/00006450-198411000-00011

10.1111/j.1651-2227.1994.tb13156.x

10.1111/j.1651-2227.2001.tb02446.x

Green OC., 1983, Textbook of Cystic Fibrosis., 329

Gorvoy JD., 1617, Cataracts, arterio‐vascular calcifications, and retinopathy in a patient with cystic fibrosis and diabetes mellitus, Cystic Fibrosis Club Abstracts., 26, 178

10.1056/NEJM198604103141514

10.1016/S0954-6111(98)90390-0

10.1111/j.1651-2227.1994.tb12956.x

Sullivan MM, 1989, Diabetic microangiopathy in patients with cystic fibrosis, Pediatrics, 84, 642, 10.1542/peds.84.4.642

Oppenheimer EH., 1972, Glomerular lesions in cystic fibrosis: possible relation to diabetes mellitus, acquired cyanotic heart disease and cirrhosis of the liver, John Hopkins Med J, 131, 351

10.1056/NEJM198609183151215

10.1056/NEJM199503303321303

Conway SP, 2000, Cystic Fibrosis in Children and Adults: The Leeds Method of Management.

Abdul‐Karim FW, 1986, Islets of Langerhans in adolescents and adults with cystic fibrosis, Arch Pathol Lab Med, 110, 602

10.1007/BF00718598

10.1016/S0046-8177(84)80191-4

10.3109/15513818609025923

10.1007/BF00427003

10.1210/jc.81.3.1267

Matthews DR, 1997, Textbook of Diabetes., 21.1

Wilmhurst EG, 1975, Endogenous and exogenous insulin response in patients with cystic fibrosis, Pediatrics, 55, 75, 10.1542/peds.55.1.75

10.1111/j.1365-2265.1993.tb01746.x

10.1530/acta.0.1280207

10.1007/BF02072102

10.1016/S0022-3476(05)80032-0

Lanng S., 1997, Glucose intolerance in cystic fibrosis, Dan Med Bull, 44, 23

10.1016/S0022-3476(77)81241-9

10.1136/adc.68.1.123

10.1016/S0022-3476(74)80756-0

Larsen S, 1988, Pancreatic hormone secretion in chronic pancreatitis without residual beta‐cell function, Acta Endocrinol, 118, 357

Nousia‐Arvanitakis S, 1985, Pancreatic polypeptide in cystic fibrosis, Arch Pathol Lab Med, 109, 722

Mohan V, 1985, Insulin and C‐peptide responses to glucose load in cystic fibrosis, Diabet Metab, 11, 376

10.1111/j.1651-2227.1988.tb10599.x

10.1111/j.1365-2265.1994.tb02533.x

10.1016/0026-0495(94)90239-9

10.1210/jc.79.1.80

10.1530/eje.0.1300253

Moran A, 1994, Insulin sensitivity in cystic fibrosis, Diabetes, 43, 1020, 10.2337/diab.43.8.1020

10.1016/S0022-3476(97)70282-8

10.2337/diabetes.48.5.1082

10.1203/00006450-199610000-00011

10.1016/S0022-3476(96)70068-9

10.1093/ajcn/41.5.1061

10.2337/diabetes.50.6.1336

10.1542/peds.101.3.433

10.1016/S0022-3476(86)80695-3

10.1210/jc.76.3.559

Flatt JP., 1978, The biochemistry of energy expenditure, Rec Adv Obes Res, 2, 211

10.1016/S0140-6736(77)90359-2

10.1016/0002-8223(94)90095-7

Figuero V, 2002, Abnormal lipid concentrations in cystic fibrosis, Am J Clin Nutr, 75, 1005, 10.1093/ajcn/75.6.1005

10.1136/adc.62.8.805

10.2337/diacare.22.6.1008

10.2337/diacare.21.6.943

10.2337/diacare.21.4.671

10.1136/thx.54.1.40

Moran A., 1998, Highlights of the February 1998 consensus conference on CFRD, Paediatr Pulmonol, 104

10.1016/S0889-8529(05)70102-X

1990, Cystic Fibrosis Foundation Conference on CF‐Related Diabetes Mellitus, Tysons Corner, VA, 11–12 January 1990., 1

10.1136/thx.54.8.750d

10.1097/00005176-198811001-00003

10.1054/clnu.1999.0079

Ashworth FA, 1999, The management of cystic fibrosis related diabetes, Br J Homecare, 1, 136

Metropolitan height and weight tables.Stat Bull Metrop Life Found1983;64:3–9.

10.1136/adc.77.6.497

10.1016/S0002-8223(95)00121-2

10.1177/0148607196020003182

10.1046/j.1365-277X.1998.00091.x

10.1016/S0022-3476(94)70312-4

10.1097/00005176-198904000-00010

10.1016/S0022-3476(98)70443-3

10.1136/gut.44.1.87

10.1054/clnu.1999.0081

10.1177/0148607186010003289

10.1093/ajcn/55.1.108

Yacoub MY, 1990, Heart‐lung transplant for cystic fibrosis and subsequent domino heart transplant, J Heart Transpl, 9, 459

Ramirez JC, 1992, Bilateral lung transplantation for cystic fibrosis, J Thorac Cardiovasc Surg, 103, 287, 10.1016/S0022-5223(19)35030-5

10.1053/prrv.2000.0032

10.1136/thorax.56.10.746

10.1378/chest.112.6.1685

10.1016/S0041-1345(97)01285-2

Kent NE, 1993, Cystic fibrosis and pregnancy, Can Med Assoc J, 149, 809

10.1111/j.1471-0528.2000.tb11697.x

Luder E, 1990, Current recommendations for breast feeding in cystic fibrosis centres, Am J Dis Child, 144, 1153

FitzSimmons SC, 1996, A longitudinal study of the effects of pregnancy on 325 women with cystic fibrosis, Pediatr Pulmonol Suppl, 13, 99

McFadyen IR., 1995, Turnbull's Obstetrics, 115

Zipf W., 1995, Therapeutic options for treatment of diabetes mellitus in cystic fibrosis, Paediatr Pulmonol Suppl, 5, 111

10.1002/ppul.1143

10.1053/prrv.2001.0148

Thông tin
Thông tin xuất bản

Diabetic Medicine

Tập 20 Số 6

425-436

Thông tin tác giả